The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 28, 2022

Filed:

Jan. 19, 2017
Applicants:

Tosoh Corporation, Yamaguchi, JP;

Tokyo Metropolitan Government, Tokyo, JP;

Inventors:

Yasuyuki Akiyama, Kanagawa, JP;

Atsushi Morimoto, Kanagawa, JP;

Toru Futami, Kanagawa, JP;

Fumiaki Koizumi, Tokyo, JP;

Takeshi Sawada, Tokyo, JP;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/49 (2006.01); G01N 33/574 (2006.01); G01N 33/50 (2006.01); G01N 33/487 (2006.01); G01N 15/02 (2006.01); G01N 33/48 (2006.01); G01N 15/10 (2006.01); G01N 15/00 (2006.01); G01N 15/06 (2006.01); G01N 15/14 (2006.01);
U.S. Cl.
CPC ...
G01N 33/491 (2013.01); G01N 15/0205 (2013.01); G01N 33/48 (2013.01); G01N 33/48735 (2013.01); G01N 33/5002 (2013.01); G01N 33/574 (2013.01); G01N 33/57492 (2013.01); G01N 2015/0019 (2013.01); G01N 2015/0294 (2013.01); G01N 2015/0693 (2013.01); G01N 2015/1006 (2013.01); G01N 2015/1081 (2013.01); G01N 2015/1087 (2013.01); G01N 2015/1486 (2013.01); G01N 2333/4742 (2013.01); G01N 2333/70589 (2013.01);
Abstract

The purpose of the present invention is to provide a method for accurately predicting a cancer patient prognosis based on a count of desired cells for which expression of a leukocyte marker and an epithelial marker is hardly exhibited by detecting those cells. Provided is a method for diagnosing an overall survival prognosis for a patient suffering from cancer, the method including: a step of obtaining a concentrated solution containing desired cells by pre-treating a biological sample obtained from the patient; a step of optically detecting the concentrated cells; and a step of detecting the desired cells from the detected image, wherein an association is made with the overall survival prognosis diagnosis by counting the detected desired cells, and wherein the desired cells are cells confirmed by the existence of a cell nucleus and in which expression of a leukocyte marker and an epithelial marker is hardly exhibited.


Find Patent Forward Citations

Loading…